Oncology Strategy Lead @IQVIA_Biotech. Opinions my own.
London
Joined October 2011
- Tweets2.2K
- Following324
- Followers437
- Likes1.9K
Sequencing whole genome of newborns will be ‘transformational’ in earlier diagnosis and treatment of rare diseases...
theguardian.com/society/2024… – at London, England
47
Matt Simmons 💊 retweeted
📊 Shifts in global clinical trial distribution: Europe's share declines across most segments, while China sees growth, except in biosimilars. More on these regional trends from our Rethinking Clinical Trial Country Prioritization report: bit.ly/3XE9hAQ. #ClinicalTrials
What else is needed in the near-term to change the trajectory of the past five years and increase Europe’s share of global oncology trial sites ? #ESMO24
2
62
The latest performance data from the UK’s MHRA reveal that clinical trial applications continue to be handled within the target statutory timescales - average of 27 days compared with the statutory timescales of 30 days)
gov.uk/government/publicatio…
23
Join me at the @IQVIA_Institute multi-stakeholder symposium ahead of #ESMO24 in Barcelona...
events.iqvia.com/event/IQVIA…
1
85
The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing— Challenging the “more is better” dogma journals.sagepub.com/doi/ful… – at Richmond, London
26
Noteworthy advances in oncology R&D shared during #ASCO24 enhancing the art of cancer care and potentially transforming treatment approaches for patients... pharmaphorum.com/oncology/as… – at Richmond, London
1
29
Although careful consideration is necessary to determine which #clinicaltrials in #oncology are well suited for inclusion of pragmatic design features, there is growing momentum to simplify, broaden access and increase generalizability of study data.... ascopubs.org/doi/10.1200/EDB… – at Lambeth, London
1
16
"In Phase I trials, #AI-discovered molecules are substantially more successful than historic industry averages..."
sciencedirect.com/science/ar… – at Richmond, London
1
26
